All News about Pharvaris N.V.
Pharvaris Provides Business Update and Expands Development Program for Deucrictibant
September 05, 2024
From Pharvaris N.V.
Via GlobeNewswire
Pharvaris Presents Data at the Bradykinin Symposium 2024
September 05, 2024
From Pharvaris N.V.
Via GlobeNewswire
Analyst Expectations for Pharvaris's Future
December 07, 2023
Via Benzinga
Pharvaris Announces Annual Meeting of Shareholders
June 11, 2024
From Pharvaris N.V.
Via GlobeNewswire
From Pharvaris N.V.
Via GlobeNewswire
From Pharvaris N.V.
Via GlobeNewswire
From Pharvaris N.V.
Via GlobeNewswire
Pharvaris Announces Extraordinary Meeting of Shareholders
February 16, 2024
From Pharvaris N.V.
Via GlobeNewswire
Pharvaris to Present at the WSAAI Annual Meeting 2024
January 26, 2024
From Pharvaris N.V.
Via GlobeNewswire
FDA Clears Pharvaris' Trial For Investigational Drug For Swollen Blood Vessels, Stock Jumps
January 22, 2024
Via Benzinga
Exposures
Product Safety
From Pharvaris N.V.
Via GlobeNewswire
Gold Moves Higher; Campbell Soup Earnings Top Expectations
December 06, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.